ArticleGene therapy2014

Re-engineered p53 activates apoptosis in vivo and causes primary tumor regression in a dominant negative breast cancer xenograft model.

A Okal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.